Role of the FDA in Affordability of Off-Patent Pharmaceuticals

JAMA. 2016 Feb 2;315(5):461-2. doi: 10.1001/jama.2015.18720.

Authors

Jeremy A Greene¹, Gerard Anderson², Joshua M Sharfstein²

Affiliations

¹ Department of Medicine and Institute of the History of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

PMID: 26747694
DOI: 10.1001/jama.2015.18720

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Commerce
Drug Approval* / legislation & jurisprudence
Drug Compounding*
Drug Costs
Drug Industry
Drugs, Generic* / economics
Drugs, Generic* / supply & distribution
Humans
United States
United States Food and Drug Administration*

Substances

Drugs, Generic